Drug intelligence / Profile preview

Jingyin Granules

Development stage
Unknown
Lead developer
Shuguang Hospital
Administration
Oral
01

Overview

Jingyin Granules is a marketed traditional Chinese medicine (TCM) herbal formulation developed as an in-hospital preparation at Shanghai Shuguang Hospital, affiliated with Shanghai University of Traditional Chinese Medicine. It is a complex multi-herb mixture derived from the classical TCM formula Yinqiao Powder, composed of nine herbs including Herba Schizonpetae (Jing Jie), Flos Lonicerae (Jin Yin Hua), Herba Taraxaci (Pu Gong Ying), Indigowoad Leaf (Da Qing Ye), and Folium Ilicis Purpureae (Si Ji Qing). Clinically used for over 40 years, it is indicated for respiratory diseases such as acute bronchitis, acute pneumonia, H1N1 influenza A virus infection, and COVID-19. The formulation exhibits antiviral and anti-inflammatory properties and has been shown to inhibit various drug-metabolizing enzymes, including carboxylesterases and cytochrome P450 isoforms.

Brand names
Jingyin Granules
Other names
荆银颗粒Jingyin granule
02

Targets

CES1 (Liver carboxylesterase 1)CES2 (Carboxylesterase 2)CYP1A (Cytochrome P450 family 1 subfamily A)CYP2A6 (Cytochrome P450 2A6)CYP2C8 (Cytochrome P450 2C8)CYP2C9 (Cytochrome P450 family 2 subfamily C member 9)CYP2D6 (Cytochrome P450 2D6)CYP2E1

Beyond the preview

Go deeper on Jingyin Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jingyin Granules.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call